Celularity Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +0.0% | -162.7% | – | – | – | – | |
| – | -47.6% | +0.0% | -8.0% | +6.5% | -17.5% | -1.0% | +0.0% | -2.2% | -0.5% | -1.2% | +0.0% | – | |
| – | -6.7% | +0.0% | -17.6% | +20.5% | -25.3% | +16.0% | +0.0% | -21.0% | -16.6% | +59.3% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +51.8% | -88.1% | -1,077.3% | – | – | +11.8% | +0.0% | +51.4% | -54.7% | +17.6% | +0.0% | – | |
| – | +635.5% | +0.0% | -82.9% | +1,387.2% | -94.0% | +60.0% | +0.0% | -100.0% | +5,599,900.0% | -100.0% | – | – | |
| – | – | – | – | – | -94.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -107.1% | -16.7% | – | -200.6% | – | – | |
| – | +2.3% | +0.0% | +8.5% | -100.2% | +464.3% | – | +0.0% | +153.7% | +113.2% | +222.6% | +0.0% | – | |
| – | – | – | – | -376.5% | – | – | +0.0% | -16.3% | -230.4% | – | +0.0% | – | |
| – | – | – | – | – | – | – | +0.0% | -165.0% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.